You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2025

CLINICAL TRIALS PROFILE FOR SELENIOUS ACID


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for selenious acid

Trial IDTitleStatusSponsorPhaseStart DateSummary
NCT05661682 ↗ Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition Not yet recruiting American Regent, Inc. Phase 4 2022-12-31 Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in adult patients requiring long-term parenteral nutrition.
NCT05136378 ↗ Selenious Yeast in CLL Patients w/o Indication of Chemotherapy Recruiting Shanghai Changzheng Hospital N/A 2021-11-01 The purpose of this study is to evaluate the safety and effectiveness of Selenious Yeast Tablets in Chronic Lymphocytic Leukemia Patients without Indication of Chemotherapy
NCT05136378 ↗ Selenious Yeast in CLL Patients w/o Indication of Chemotherapy Recruiting Shanghai Zhongshan Hospital N/A 2021-11-01 The purpose of this study is to evaluate the safety and effectiveness of Selenious Yeast Tablets in Chronic Lymphocytic Leukemia Patients without Indication of Chemotherapy
>Trial ID>Title>Status>Phase>Start Date>Summary
Showing 1 to 3 of 3 entries

Clinical Trial Conditions for selenious acid

Condition Name

1110-0.100.10.20.30.40.50.60.70.80.911.1Chronic Lymphocytic Leukemia Stage A(I)Chronic Lymphocytic Leukemia Stage A(II)Manganese Safety in Adults[disabled in preview]
Condition Name for selenious acid
Intervention Trials
Chronic Lymphocytic Leukemia Stage A(I) 1
Chronic Lymphocytic Leukemia Stage A(II) 1
Manganese Safety in Adults 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

1110-0.100.10.20.30.40.50.60.70.80.911.1Leukemia, LymphoidLeukemia, Lymphocytic, Chronic, B-CellLeukemia[disabled in preview]
Condition MeSH for selenious acid
Intervention Trials
Leukemia, Lymphoid 1
Leukemia, Lymphocytic, Chronic, B-Cell 1
Leukemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for selenious acid

Trials by Country

+
Trials by Country for selenious acid
Location Trials
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for selenious acid

Clinical Trial Phase

66.7%33.3%0-0.200.20.40.60.811.21.41.61.822.2Phase 4N/A[disabled in preview]
Clinical Trial Phase for selenious acid
Clinical Trial Phase Trials
Phase 4 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

66.7%33.3%0-0.200.20.40.60.811.21.41.61.822.2Not yet recruitingRecruiting[disabled in preview]
Clinical Trial Status for selenious acid
Clinical Trial Phase Trials
Not yet recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for selenious acid

Sponsor Name

trials000111112222American Regent, Inc.Shanghai Changzheng HospitalShanghai Zhongshan Hospital[disabled in preview]
Sponsor Name for selenious acid
Sponsor Trials
American Regent, Inc. 2
Shanghai Changzheng Hospital 1
Shanghai Zhongshan Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

50.0%50.0%0-0.200.20.40.60.811.21.41.61.822.2OtherIndustry[disabled in preview]
Sponsor Type for selenious acid
Sponsor Trials
Other 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Selenious Acid: Clinical Trials, Market Analysis, and Projections

Introduction to Selenious Acid

Selenious acid, a compound of selenium, has been the focus of various clinical trials and market analyses due to its diverse applications in medicine, electronics, and catalysis. Here, we will delve into the recent clinical trials, market trends, and future projections for selenious acid.

Clinical Trials: Medical Applications

Selenium in Migraine Treatment

A recent double-blinded randomized clinical trial investigated the effect of selenium supplementation on oxidative stress and clinical symptoms in patients with migraine. The study found that selenium supplementation had beneficial effects on oxidative stress and migraine symptoms, suggesting it could be a complementary therapy for migraine patients[1].

Selenium in Cancer Treatment

In the realm of cancer treatment, a phase I trial evaluated the safety and efficacy of combining selenium with chemotherapy in women with gynecologic cancers. The trial administered selenious acid in doses ranging from 50 μg to 5000 μg and found that the addition of selenium to carboplatin and paclitaxel chemotherapy was safe and well-tolerated, with no effect on carboplatin pharmacokinetics. A dose of 5000 μg of elemental selenium as selenious acid was suggested for further evaluation in a phase II trial[3].

Selenium and Vitamin E in Bladder Cancer Prevention

Another clinical trial, the SELENIB trial, assessed the ability of selenium and vitamin E to prevent non–muscle-invasive bladder cancer (NMIBC). The trial randomized patients to receive selenium, vitamin E, both, or placebos. Although the trial was halted due to slow accrual, it did not find a preventive effect of selenium or vitamin E alone or combined on bladder cancer recurrence and progression[4].

Market Analysis

Current Market Size and Growth

The selenious acid market has experienced significant growth in recent years and is anticipated to continue this trend. The market size is expected to expand substantially from 2023 to 2031, driven by increasing demand from various industries[2].

Key Drivers of the Market

Electronics Industry

The primary driver of the selenious acid market is the growing demand from the electronics industry. Selenious acid is used as an oxidizing agent in the production of semiconductor devices, LCD panels, and photovoltaic cells. The increasing global demand for advanced electronic products has contributed to the increased adoption of selenious acid in this sector[5].

Catalysis Industry

Another key driver is the catalysis industry, where selenious acid is employed as a catalyst in the synthesis of organic compounds and in industrial processes such as the production of sulfuric acid. The emphasis on developing efficient and environmentally friendly catalytic systems has driven the demand for selenious acid-based solutions[5].

Regional Analysis

Established Markets

North America and Europe are currently the largest and most established markets for selenious acid, driven by the strong presence of the electronics, catalysis, and specialty chemicals industries, as well as well-developed regulatory frameworks[5].

Emerging Markets

The Asia-Pacific region is expected to witness the fastest growth in the selenious acid market, particularly in countries like China, Japan, and South Korea. This growth is driven by the expanding electronics manufacturing sector, the increasing emphasis on renewable energy solutions, and growing investment in advanced industrial technologies[5].

Latin America and Middle East & Africa

These regions are also emerging as potential growth markets for selenious acid as they develop their industrial capabilities and address the growing demand for efficient and reliable chemical solutions[5].

Market Projections

Forecasted Growth

The selenious acid market is projected to witness exponential growth at a significant Compound Annual Growth Rate (CAGR) from 2024 to 2033. This growth is attributed to the increasing demand from the electronics and catalysis industries, as well as the expanding industrial capabilities in emerging regions[5].

Regional Expansion

The market is expected to expand globally, with North America and Europe maintaining their dominance while the Asia-Pacific region experiences rapid growth. Latin America and the Middle East & Africa are also expected to contribute significantly to the market's expansion[5].

Challenges and Opportunities

Regulatory Frameworks

The handling and use of selenious acid are governed by strict regulatory frameworks, particularly in established markets. Compliance with these regulations is crucial for market growth and expansion[5].

Environmental Concerns

The use of selenious acid in industrial processes must be balanced with environmental considerations. The development of environmentally friendly catalytic systems using selenious acid presents both challenges and opportunities for the market[5].

Key Takeaways

  • Clinical Trials: Selenious acid has shown promise in clinical trials for treating migraine and as a complementary therapy in cancer treatment, though its effectiveness in preventing bladder cancer recurrence is inconclusive.
  • Market Growth: The selenious acid market is expected to grow significantly driven by demand from the electronics and catalysis industries.
  • Regional Expansion: North America and Europe are established markets, while the Asia-Pacific region is expected to experience rapid growth.
  • Regulatory and Environmental Considerations: Compliance with regulatory frameworks and addressing environmental concerns are critical for market expansion.

FAQs

What are the primary medical applications of selenious acid?

Selenious acid is being studied for its potential in treating migraine, as a complementary therapy in cancer treatment, and in preventing non–muscle-invasive bladder cancer.

Which industries drive the demand for selenious acid?

The electronics and catalysis industries are the primary drivers of the selenious acid market, with growing demand for advanced electronic products and efficient catalytic systems.

What regions are expected to see the fastest growth in the selenious acid market?

The Asia-Pacific region, particularly countries like China, Japan, and South Korea, is expected to witness the fastest growth in the selenious acid market.

What are the regulatory challenges for the selenious acid market?

The market must comply with strict regulatory frameworks, especially in established markets like North America and Europe, to ensure safe handling and use of selenious acid.

How does environmental concern impact the selenious acid market?

The development of environmentally friendly catalytic systems using selenious acid is crucial to balance industrial needs with environmental sustainability, presenting both challenges and opportunities for market growth.

Sources

  1. Frontiers in Nutrition: "The effect of selenium supplementation on oxidative stress, clinical, and physiological symptoms in patients with migraine."
  2. Market Research Intellect: "Global Selenious Acid Market Size, Scope And Forecast Report."
  3. PubMed: "Phase I trial of selenium plus chemotherapy in gynecologic cancers."
  4. JAMA Network Open: "Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer."
  5. Data Horizon Research: "Selenic Acid Market Size, Share, Growth, Statistics Report 2033."

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.